SecBot SecBot
Insider Cluster (4 insiders) ·Filed Sep 9, 2026

ARTV

Artiva Biotherapeutics, Inc.
BEARISH
Impact 5/10
Horizondays Processed2mo ago
Insider cluster: 4 insiders, $0.5M total
Actionable Insight ▼ Bearish

The C-suite selling cluster, while small in dollar terms, is a bearish signal given the breadth of executive participation. Monitor for any upcoming negative catalysts (data readouts, financing, or guidance changes) that may have prompted the sales. The 92% analyst bullishness and strong historical insider buy signals create a contrarian setup, if the stock breaks below $10 support, the selling could accelerate.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$10.42
T+0 close · Sep 9, 2026 · via day close
Latest settled
−34.74%
T+20 · $6.80 · next T+60 in 17d
Vs SPY
−37.12%
α at T+20
Latest observation
−55.11%
T+46 · FF3 residual α
  1. T+0 · Sep 10 $10.42entry
  2. T+1 · 2mo ago −1.92%α −2.77% · $10.22
  3. T+5 · 2mo ago −19.00%α −19.63% · $8.44
  4. T+20 · 6w ago −34.74%α −37.12% · $6.80
  5. T+47 · todayOpen
  6. T+60 · in 17d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A cluster of insider selling at Artiva Biotherapeutics, totaling $477K in open-market sales by the CEO, COO/CLO, CTO, and CMO over a 5-day window. The CEO's $256K sale on Sept 8 is the largest, and the selling is concentrated among top C-suite executives. While the dollar amount is modest relative to the $532M market cap (~0.09%), the breadth of C-suite participation is notable. The cross-filing context shows the CEO also sold $256K in a separate transaction on the same day, reinforcing the pattern. The stock trades near $11, with 92% analyst bullishness, creating a tension between insider behavior and street sentiment.

Key Financial Metrics

Direction
selling
Total Value
$477.0K
Insiders
4

Key Facts

  • CEO Fred Aslan sold 23,429 shares for $256K on Sept 8
  • COO/CLO Jennifer Bush sold 8,400 shares for $94K on Sept 3
  • CTO Christopher Horan sold 10,400 shares for $116K on Sept 3
  • CMO Subhashis Banerjee sold 1,100 shares for $12K on Sept 3
  • Total insider selling of $477K represents ~0.09% of $532M market cap
  • All four selling insiders are C-suite executives (CEO, COO/CLO, CTO, CMO)
  • No insider purchases were reported in the cluster window
  • Six directors received non-cash stock grants of 13,750 shares each on Sept 8

Financial Impact

Total insider selling of $477K, or ~0.09% of market cap, concentrated among four C-suite executives

insider ownershipmarket sentiment

Risk Factors

  • Insider selling may be liquidity-driven (10b5-1 plans, tax planning) rather than informational
  • Small dollar amount relative to market cap limits materiality
  • Strong analyst consensus and historical buy signals could mean selling is opportunistic, not fundamental

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARTV-1789030940849

Track record

33 reports on ARTV

Performance horizon

10 of 15 bullish or bearish reports moved the stock their way by T+20. Best: +66.32% at T+60 after the Jun 8, 2026 report. 16 of 18 went positive at some point.

Filters
  1. Nov 9, 20267d ago 8-K/A Bearish 7/10 Entry $4.06 Now $3.96 +2.46% settles Dec 9
  2. Nov 3, 202613d ago Insider Cluster Bearish 6/10 Entry $4.22 Now $3.96 +6.16% settles Dec 3
  3. Oct 27, 202620d ago 8-K Bearish 6/10 Entry $4.27 Now $3.96 +7.26% settles Nov 24
  4. Oct 6, 20265w ago 144 Neutral 3/10 Entry $7.00 to $4.21 Now $3.96 −43.43% ▼ −39.93% −38.69% vs SPY
  5. Sep 11, 20269w ago 8-K Neutral 3/10 Entry $10.14 to $6.77 Now $3.96 −60.95% ▼ −33.23% −35.50% vs SPY
  6. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  7. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  8. Sep 9, 20269w ago Insider Cluster Neutral 4/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  9. Sep 9, 20269w ago Insider Cluster Neutral 3/10 Entry $10.42 to $6.80 Now $3.96 −62.00% ▼ −34.74% −37.12% vs SPY
  10. Sep 9, 20269w ago Insider Cluster Bearish 5/10 Viewing Entry $10.42 to $6.80 Now $3.96 +62.00% ▲ +34.74% +37.12% vs SPY
Showing 10 of 33

US Market Status

Market Closed · Opens in 8h 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 10, 2026